Granulation Technology, Inc || About Us

GTI is a FDA GDUFA listed facility

Granulation Technology, Inc. is a chemical and pharmaceutical manufacturing and distribution company that has been in business since 1997 successfully serving small to Fortune 500 companies. GTI is a FDA GDUFA listed facility. It is a fully functional 35,000 sq. ft. cGMP facility. DEA Registered to handle Class III - V controlled subtances. We have been consistently adding to our large list of clientele ensuring their high demands for quality & safety standards in their products are met. At Granulation Technology, Inc we strive to provide the highest quality products that comply with FDA regulations, meet USP and are manufactured under GMP and ISO standards. This approach insures high quality products while providing cost competitive advantages.

Who We are

We provide wet and dry granulations of multiple products. We also offer encapsulation services, Capsule banding, Blending, tableting, packaging of tablets and. packaging of pouches. Our responsibilities include factory audits, regulatory issues, outside third party testing & verification. This will insure we meet the highest standards while providing the most consistent quality products available in the market.

We can meet the stringent of specifications and adhering to the specific guidelines our customers require. Granulation Technology, Inc, is committed to providing fast, reliable and consistent service to all customers, new and old, at home and abroad. We sincerely welcome you to contact us with any inquiries you may have.

Our History

2017

Amit Nigalaye is appointed the President of GTI who will be taking the company to new heights.

2012

Relocated to current location in 2012. FDA GDUFA listed facility. It is a fully functional 35,000 sq. ft. cGMP facility. DEA Registered to handle Class III - V controlled subtances.

2001

Recieved contract to manufacture a NDA product from 2001 - 2014

1997

Established in 1997 by Ashok G. Nigalaye to provide custom granulation for OTC and prescription products. It was 10,000 sq. ft. FDA GDUFA listed facility.